CARCINOMA IN SITU

Clinical trials for CARCINOMA IN SITU explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA IN SITU trials appear

Sign up with your email to follow new studies for CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1 Terminated 1

New bladder cancer drug tested in patients who failed standard therapy

Disease control Terminated

This study tested a new drug called enfortumab vedotin for patients with a type of bladder cancer that hasn't spread into the muscle wall. The drug was delivered directly into the bladder through a thin tube. The main goals were to find a safe dose and see if it could help contro…

Matched conditions: CARCINOMA IN SITU

Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

CARCINOMA IN SITU

Get alerted when new CARCINOMA IN SITU trials appear

New bladder cancer drug tested in patients who failed standard therapy